Materials – Tokyo Hepatitis Clinical Forum 2019

 

Monday 28 October 2019

 Session 1 - Hepatitis/ liver diseases in Japan
Chairs: Kazuhiko Koike & Charles Boucher
 

Epidemological trends in viral Hepatitis B and C in Japan
(No permission to publish slides)
Junko Tanaka, MD, PhD
Hiroshima University, Japan

 

Trend of NAFLD/ NASH in Japan
(No video available)
Katsutoshi Tokushige, MD
Tokyo Women’s Medical University, Japan

 

Trends in epidemiology of hepatitis B and HCC in Asia
(No video available)
Sang Hoon Ahn, MD, PhD
Yonsei University College of Medicine, South Korea

 Session 2 - Clinical management of Hepatitis C
Chairs: Tesuo Takehara & Man-Fung Yuen
 State-of-the-Art: Current clinical management of hepatitis C in Japan
(No permission to publish slides or video)

Nobuyuki Enomoto, MD, PhD
University of Yamanashi, Japan
 

Hepatitis C management in special populations
Mark Nelson, MD
Chelsea And Westminster Hospital, United Kingdom

 

 

Challenges in the era of hepatitis C cure
Naoya Sakamoto, MD
Hokkaido University, Japan

 

 HCV-associated HCC - Basics and clinics
(No permission to publish slides or video)

Naoya Kato, MD, PhD
Chiba University, Japan
 Session 3 - Clinical management of Hepatitis B
Chairs: Naoya Kato & Naoya Sakamoto
 State-of-the-Art: Current clinical management of hepatitis in Japan
(No permission to publish slides or video)

Hiroshi Yatsuhashi, MD
NHO Nagasaki Medical Center, Japan
 

Management of Hepatitis B reactivation
(No video available)
Yasuhito Tanaka, MD, PhD
Nagoya City University, Japan

 

Co-infection of HIV, HBV and HCV
(No permission to publish slides or video)

Hiroyuki Gatanaga, MD, PhD
National Center For Global Health And Medicine, Japan

 

New anti-HBV drugs in the pipeline
(No video available)
Man-Fung Yuen, DSc, MD, PhD
University of Hong Kong, Hong Kongyyy

 

Tuesday 29 October 2019

 Session 4 - Hepatitis C elimination strategies
Chairs: Nobuyuki Enomoto & Peter Revill
 

Update on Hepatitis C elimination strategies
(No permission to publish slides)

Margaret Hellard, MD
Burnet Institute, Australia

 

Immunological aspects of HBV and HCV infection 
Tatsuya Kanto, MD, PhD
National Center for Global Health and Medicine, Japan

 Current treatment of decompensated cirrhosis
(No permission to publish slides or video)

Tetsuo Takehara, MD
Osaka University, Japan
 Session 5 - Future clinical management of liver diseases
Chairs: Yasuhito Tanaka & Margaret Hellard
 

Progress in Hepatitis B cure research
Peter Revill, MD, PhD
Victorian Infectious Diseases Reference Laboratory, Australia

 

 Current and future treamtments of NASH
(No permission to publish slides or video)

Atsushi Nakajima, MD
Yokohama City University, Japan
 

Current and future local therapies for early stage HCC
Shi-Ming Lin, MD
Linkou Chang Gung Memorial Hospital, Taiwan

 

 

Evolving treatment paradigm and future landscape in HCC
Masafumi Ikeda, MD
National Cancer Center Hospital East, Japan

 

 

Closure of the conference
Kazuhiko Koike, MD, PhD
University of Tokyo, Japan